A three enzyme system to generate the Strychnos alkaloid scaffold from a 
central biosynthetic intermediate

Tatsis, Evangelos C.; Carqueijeiro, Inês; de Bernonville, Thomas Dugé; Franke, Jakob; Dang, Thu-Thuy T.; Oudin, Audrey; Lanoue, Arnaud; Lafontaine, Florent; Stavrinides, Anna K.; Clastre, Marc; Courdavault , Vincent   Sarah E.; O’Connor, Sarah E.

doi:10.1038/s41467-017-00154-x

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

A three enzyme system to generate the Strychnos alkaloid scaffold from a central biosynthetic intermediate

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

http://dx.doi.org/10.1038/s41467-017-00154-x
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

EXT640.pdf
(Publisher version), 717KB

Supplementary Material (public)

EXT640s1.pdf
(Supplementary material), 6MB

EXT640s2.xlsx
(Supplementary material), 107KB

Citation

Tatsis, E. C., Carqueijeiro, I., de Bernonville, T. D., Franke, J., Dang, T.-T.-T., Oudin, A., et al. (2017). A three enzyme system to generate the Strychnos alkaloid scaffold from a central biosynthetic intermediate. Nature Communications, 8: 316. doi:10.1038/s41467-017-00154-x.

Cite as: https://hdl.handle.net/21.11116/0000-0003-96A0-E

Abstract

Monoterpene indole alkaloids comprise a diverse family of over 2000 plant-produced natural
products. This pathway provides an outstanding example of how nature creates chemical
diversity from a single precursor, in this case from the intermediate strictosidine. The
enzymes that elicit these seemingly disparate products from strictosidine have hitherto been
elusive. Here we show that the concerted action of two enzymes commonly involved in
natural product metabolism—an alcohol dehydrogenase and a cytochrome P450—produces
unexpected rearrangements in strictosidine when assayed simultaneously. The tetrahydro-β-
carboline of strictosidine aglycone is converted into akuammicine, a Strychnos alkaloid, an
elusive biosynthetic transformation that has been investigated for decades. Importantly,
akuammicine arises from deformylation of preakuammicine, which is the central biosynthetic
precursor for the anti-cancer agents vinblastine and vincristine, as well as other biologically
active compounds. This discovery of how these enzymes can function in combination opens a gateway into a rich family of natural products.